Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 501

1.

Hormone replacement therapy after cancers.

Creasman WT.

Curr Opin Oncol. 2005 Sep;17(5):493-9. Review.

PMID:
16093802
2.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
4.

Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.

Pike MC, Ross RK.

Steroids. 2000 Oct-Nov;65(10-11):659-64.

PMID:
11108873
6.

Breast cancer and HRT--what are the data?

Bieber EJ, Barnes RB.

Int J Fertil Womens Med. 2001 Mar-Apr;46(2):73-8. Review.

PMID:
11374658
7.

Use of HRT and the subsequent risk of cancer.

Beral V, Banks E, Reeves G, Appleby P.

J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. Review.

PMID:
10695959
8.

Hormone replacement and cancer.

Barrett-Connor E.

Br Med Bull. 1992 Apr;48(2):345-55. Review.

PMID:
1450874
9.

Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast.

Burger CW, Kenemans P.

Curr Opin Obstet Gynecol. 1998 Feb;10(1):41-5. Review.

PMID:
9484628
10.

Relationship of hormone use to cancer risk.

Bernstein L, Ross RK, Henderson BE.

J Natl Cancer Inst Monogr. 1992;(12):137-47. Review.

PMID:
1616798
11.

Hormone replacement therapy and estrogen-dependent cancers.

Birkhäuser M.

Int J Fertil Menopausal Stud. 1994;39 Suppl 2:99-114. Review.

PMID:
7874193
12.

Estrogen replacement therapy in patients with early breast cancer.

Natrajan PK, Gambrell RD Jr.

Am J Obstet Gynecol. 2002 Aug;187(2):289-94; discussion 294-5.

PMID:
12193914
13.

Menopause, hormone replacement therapy and cancer.

La Vecchia C, Brinton LA, McTiernan A.

Maturitas. 2001 Aug 25;39(2):97-115. Review.

PMID:
11514109
14.

Hormone replacement therapy and risk of malignancy.

Diamanti-Kandarakis E.

Curr Opin Obstet Gynecol. 2004 Feb;16(1):73-8. Review.

PMID:
15128011
15.

The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.

Bernstein L.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):288-96. Review.

16.

Hormone replacement therapy and cancer risk.

Mahavni V, Sood AK.

Curr Opin Oncol. 2001 Sep;13(5):384-9. Review.

PMID:
11555717
17.

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.

Persson I, Weiderpass E, Bergkvist L, Bergström R, Schairer C.

Cancer Causes Control. 1999 Aug;10(4):253-60.

PMID:
10482483
18.

[Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].

Magnusson C, Weiderpass E.

Lakartidningen. 2001 Jan 31;98(5):418-21. Review. Swedish.

PMID:
11229082
19.

Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.

Verheul HA, Coelingh-Bennink HJ, Kenemans P, Atsma WJ, Burger CW, Eden JA, Hammar M, Marsden J, Purdie DW.

Maturitas. 2000 Jul 31;36(1):1-17. Review.

PMID:
10989237
20.

Estrogen-replacement therapy in younger women with breast cancer.

Theriault RL, Sellin RV.

J Natl Cancer Inst Monogr. 1994;(16):149-52. Review.

PMID:
7999457

Supplemental Content

Support Center